Today during a House Committee on Energy & Commerce hearing, chief executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novovax addressed US lawmakers for the first time since July 2020 on the production of vaccines and when Americans could expect more doses.According to Richard Nettles, MD, vice president of US medical affairs for Johnson & Johnson's Janssen division, his company will be able to immediately ship vaccine doses upon a Food and Drug Administration (FDA) emergency use authorization (EUA).
An FDA advisory board meets on Feb 26 to consider granting an EUA to Johnson & Johnson."This will enable the vaccination of more than 20 million Americans by the end of March," Nettles said of an expected EUA. "And we are